Two NHS England/Improvement directors have been appointed to the board of the company behind NHS Supply Chain. 

Emily Lawson, NHSE/I’s national director for transformation and corporate operations, and Miranda Carter, the regulator’s director of provider transformation, will sit as directors on the board of Supply Chain Coordination Ltd.

Ms Lawson, a molecular geneticist, has previously worked at retail company Kingfisher plc and at management consultancy McKinsey. Last year HSJ named her the 86th most influential person in healthcare.

Ms Carter previously worked at Monitor, where she assessed NHS foundation trust applications and reviewed NHS mergers and acquisitions. She went on to head mergers and acquisitions at NHS Improvement. A chartered accountant, she previously worked at Deloitte and PwC.

She said in a statement: “My previous experience and current role at NHS England and NHS Improvement will help to boost ideas and increase the buying power of the NHS to ensure more money is available for our frontline services.”

Ms Lawson added: “This is an excellent opportunity to continue our collaboration to drive improvements for the NHS and the public. I look forward to working together to consolidate our procurement function which will help trusts save money to reinvest into patient care.”

Currently owned by the Department for Health and Social Care, news emerged in January that NHSE/I was considering acquiring SCCL. At the time, an NHSI spokesman told HSJ the regulator was performing a due diligence process on the transfer. On Wednesday, an NHSE/I spokeswoman said the regulator’s position had not changed.

NHS Supply Chain has come under fire in recent months for failing to provide timely savings reports to individual trusts. Trusts themselves fund the body’s running costs.

The procurement body—which has been tasked with delivering £2.4bn of savings by the end of the 2022-23 financial year—previously told HSJ it was working out each trust’s savings manually because of a critical “systems issue.”